Next-Generation Sequencing (NGS)-Based Clinical Testing is Recommended for the Detection of Gene Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia Predisposition Syndromes

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Gene Mutations ◽

Clinical Testing ◽

Next Generation ◽

Generation Sequencing ◽

Next-generation sequencing reveals gene mutations landscape and clonal evolution in patients with acute myeloid leukemia

Hematology ◽

10.1080/16078454.2020.1858610 ◽

2021 ◽

Vol 26 (1) ◽

pp. 111-122

Author(s):

Xiao Chen ◽

Han Zhu ◽

Chun Qiao ◽

Sishu Zhao ◽

Lu Liu ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Clonal Evolution ◽

Gene Mutations ◽

Next Generation ◽

Generation Sequencing ◽

Abstract 2299: Development of a novel next-generation sequencing (NGS)-based assay for measurable residual disease (MRD) inFLT3-ITD acute myeloid leukemia (AML) and its potential clinical application in patients

10.1158/1538-7445.am2019-2299 ◽

2019 ◽

Author(s):

Wenge Shi ◽

Christian Laing ◽

Wei Ding ◽

Marc Mycoco ◽

Jelveh Lameh ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Clinical Application ◽

Myeloid Leukemia ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Measurable Residual Disease ◽

Abstract 2299: Development of a novel next-generation sequencing (NGS)-based assay for measurable residual disease (MRD) inFLT3-ITD acute myeloid leukemia (AML) and its potential clinical application in patients

10.1158/1538-7445.sabcs18-2299 ◽

2019 ◽

Author(s):

Wenge Shi ◽

Christian Laing ◽

Wei Ding ◽

Marc Mycoco ◽

Jelveh Lameh ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Clinical Application ◽

Myeloid Leukemia ◽

Residual Disease ◽

Next Generation ◽

Generation Sequencing ◽

Measurable Residual Disease ◽

Mutation analysis in 35 cases of newly diagnosed therapy-related acute myeloid leukemia (AML) by next-generation sequencing (NGS): A clinico-pathologic correlation.

10.1200/jco.2016.34.15_suppl.e18525 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e18525-e18525

Author(s):

Parsa Hodjat ◽

Kankana Ghosh ◽

Priyanka Priyanka ◽

Beenu Thakral ◽

Keyur Patel ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Mutation Analysis ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

Next Generation ◽

Pathologic Correlation ◽

Generation Sequencing ◽

Abstract 01: Development of a targeted panel for acute myeloid leukemia (AML) by using next-generation sequencing (NGS)

10.1158/1557-3265.pmsclingen15-01 ◽

2016 ◽

Author(s):

Anup Tilak ◽

Ramakrishna Sompallae ◽

Aaron Stence ◽

Natalya Guseva ◽

Aaron Bossler

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Next Generation ◽

Generation Sequencing ◽

Identification of additional therapeutic options for de novo acute myeloid leukemia (AML) patient enabled by next generation sequencing (NGS).

10.1200/jco.2015.33.15_suppl.e18027 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e18027-e18027

Author(s):

Jason G Harb ◽

Amber N Essenmacher ◽

Karen-Sue Carlson ◽

Matthew W Anderson ◽

Durga P. Dash

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

De Novo ◽

Therapeutic Options ◽

Next Generation ◽

Generation Sequencing ◽

Impact of next-generation sequencing (NGS) on treatment selection in acute myeloid leukemia (AML).

10.1200/jco.2018.36.15_suppl.103 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 103-103

Author(s):

Rita Elias Assi ◽

Ana Alfonso Pierola ◽

Devendra KC ◽

Yasmin Mohammed Abaza ◽

Abdallah Abou Zahr ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Treatment Selection ◽

Next Generation ◽

Generation Sequencing ◽

Comparison of somatic mutations profiles from next-generation sequencing (NGS) of cell-free DNA (cfDNA) versus bone marrow (BM) in acute myeloid leukemia (AML).

10.1200/jco.2018.36.15_suppl.7051 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 7051-7051

Author(s):

Rita Elias Assi ◽

Maher Albitar ◽

Wanlong Ma ◽

Keyur Patel ◽

Koichi Takahashi ◽

...

Keyword(s):

Bone Marrow ◽

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Somatic Mutations ◽

Next Generation ◽

Free Dna ◽

Generation Sequencing ◽

Predictive Value of Detectable Somatic Mutations By Next Generation Sequencing (NGS), at Day +100 (D100) Post-Allogeneic Hematopoietic Cell Transplantation (allo-HCT) on Survival Outcomes in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2019.12.632 ◽

2020 ◽

Vol 26 (3) ◽

pp. S119-S120

Author(s):

Madiha Iqbal ◽

Ricardo Daniel Parrondo ◽

Vivek Roy ◽

Ernesto Ayala ◽

Hemant Murthy ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Somatic Mutations ◽

Hematopoietic Cell Transplantation ◽

Survival Outcomes ◽

Generation Sequencing ◽

Mutational Landscape of Intermediate-Risk and Poor-Risk Acute Myeloid Leukemia (AML) Adult Patients by Next-Generation Sequencing (NGS): One Academic Center’s Experience

American Journal of Clinical Pathology ◽

10.1093/ajcp/aqy112.361 ◽

2018 ◽

Vol 150 (suppl_1) ◽

pp. S154-S154

Author(s):

Betty Chung ◽

Jessica Thomas ◽

Randall Olsen

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Adult Patients ◽

Intermediate Risk ◽

Next Generation ◽

Mutational Landscape ◽

Generation Sequencing ◽